Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Petr Dobeš

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Journal of Computer-Aided Molecular Design|February 3, 2011
Transferable scoring function based on semiempirical quantum mechanical PM6-DH2 method: CDK2 with 15 structurally diverse inhibitorsPetr Dobeš, Jindřich Fanfrlík, Jan Rezáč, et al.
Analytica Chimica Acta|May 27, 2014
Investigation of protein FTT1103 electroactivity using carbon and mercury electrodes. Surface-inhibition approach for disulfide oxidoreductases using silver amalgam powderRenata Večerková, Lenka Hernychová, Petr Dobeš, et al.
Current Computer-Aided Drug Design|November 20, 2012
Quantum mechanical scoring: structural and energetic insights into cyclin-dependent kinase 2 inhibition by pyrazolo[1,5-a]pyrimidinesPathik S Brahmkshatriya, Petr Dobeš, Jindrich Fanfrlik, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Journal of Computer-Aided Molecular Design|February 3, 2011
Transferable scoring function based on semiempirical quantum mechanical PM6-DH2 method: CDK2 with 15 structurally diverse inhibitorsPetr Dobeš, Jindřich Fanfrlík, Jan Rezáč, et al.
Analytica Chimica Acta|May 27, 2014
Investigation of protein FTT1103 electroactivity using carbon and mercury electrodes. Surface-inhibition approach for disulfide oxidoreductases using silver amalgam powderRenata Večerková, Lenka Hernychová, Petr Dobeš, et al.
Current Computer-Aided Drug Design|November 20, 2012
Quantum mechanical scoring: structural and energetic insights into cyclin-dependent kinase 2 inhibition by pyrazolo[1,5-a]pyrimidinesPathik S Brahmkshatriya, Petr Dobeš, Jindrich Fanfrlik, et al.
Pageof 1